Goldman Sachs Group Inc Spring Works Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 421,776 shares of SWTX stock, worth $16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
421,776
Previous 386,041 9.26%
Holding current value
$16 Million
Previous $14.5 Million 7.08%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$32.04 - $42.76 $1.14 Million - $1.53 Million
35,735 Added 9.26%
421,776 $13.5 Million
Q2 2024

Aug 13, 2024
BUY
$36.06 - $47.62 $430,556 - $568,582
11,940 Added 3.19%
386,041 $14.5 Million
Q1 2024

May 15, 2024
SELL
$36.5 - $52.5 $3.18 Million - $4.58 Million
-87,174 Reduced 18.9%
374,101 $18.4 Million
Q4 2023

Feb 13, 2024
SELL
$18.94 - $37.24 $2.48 Million - $4.89 Million
-131,202 Reduced 22.14%
461,275 $16.8 Million
Q3 2023

May 14, 2024
BUY
$23.12 - $31.38 $3.03 Million - $4.12 Million
131,202 Added 28.44%
592,477 $13.7 Million
Q3 2023

Nov 14, 2023
SELL
$23.12 - $31.38 $7.26 Million - $9.86 Million
-314,092 Reduced 34.65%
592,477 $13.7 Million
Q2 2023

May 14, 2024
BUY
$23.15 - $32.71 $10.3 Million - $14.6 Million
445,532 Added 96.64%
906,569 $23.8 Million
Q2 2023

Aug 14, 2023
BUY
$23.15 - $32.71 $10.3 Million - $14.6 Million
445,532 Added 96.64%
906,569 $23.8 Million
Q1 2023

May 14, 2024
BUY
$24.97 - $34.05 $1.97 Million - $2.68 Million
78,849 Added 20.63%
461,037 $11.9 Million
Q1 2023

May 11, 2023
BUY
$24.97 - $34.05 $1.97 Million - $2.68 Million
78,849 Added 20.63%
461,037 $11.9 Million
Q4 2022

May 14, 2024
SELL
$21.73 - $28.72 $2.24 Million - $2.96 Million
-103,165 Reduced 21.26%
382,188 $9.94 Million
Q4 2022

Feb 13, 2023
SELL
$21.73 - $28.72 $2.24 Million - $2.96 Million
-103,165 Reduced 21.26%
382,188 $9.94 Million
Q3 2022

May 14, 2024
BUY
$24.1 - $39.66 $5.17 Million - $8.51 Million
214,666 Added 79.3%
485,353 $13.8 Million
Q3 2022

Nov 10, 2022
BUY
$24.1 - $39.66 $5.17 Million - $8.51 Million
214,666 Added 79.3%
485,353 $13.8 Million
Q2 2022

May 14, 2024
SELL
$18.36 - $60.07 $3.5 Million - $11.4 Million
-190,588 Reduced 41.32%
270,687 $6.67 Million
Q2 2022

Aug 15, 2022
BUY
$18.36 - $60.07 $880,876 - $2.88 Million
47,978 Added 21.54%
270,687 $6.67 Million
Q1 2022

May 16, 2022
BUY
$48.97 - $65.46 $19,685 - $26,314
402 Added 0.18%
222,709 $12.6 Million
Q4 2021

Feb 14, 2022
BUY
$53.3 - $75.84 $263,515 - $374,952
4,944 Added 2.27%
222,307 $13.8 Million
Q3 2021

Nov 10, 2021
BUY
$62.66 - $88.26 $13.6 Million - $19.2 Million
217,363 New
217,363 $13.8 Million

Others Institutions Holding SWTX

# of Institutions
238
Shares Held
69.8M
Call Options Held
144K
Put Options Held
257K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.37B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email